Physician profile
Jonathan Goike
NPI 1356736680
$1,529.24
in general payments reported to CMS, 2019-2025
19 companies · $198 in 2025
The $198 reported for 2025 was more than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $28.21 · 2023: $573 · 2024: $730 · 2025: $198.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,501.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,501.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $433.74 | 2022-2025 | |
| Medtronic, INC. | $384.06 | 2023-2024 | Intellis Adaptivestim, Activos 10 Bone Cement |
| Merz Pharmaceuticals, LLC | $132.09 | 2023-2024 | Xeomin |
| Scilex Pharmaceuticals INC. | $131.62 | 2023-2024 | Ztlido |
| Collegium Pharmaceutical, INC. | $77.72 | 2023-2024 | Belbuca |
| Teva Pharmaceuticals USA, INC. | $62.76 | 2022-2025 | Austedo Xr, Austedo Xr |
| Neurocrine Biosciences, INC. | $60.81 | 2024-2025 | Ingrezza |
| Acorda Therapeutics, INC | $27.42 | 2023 | Inbrija |
| Nalu Medical, INC. | $24.27 | 2023 | Nalu Neurostimulation System |
| Valinor Pharma, LLC | $23.15 | 2025 | Movantik |
| Averitas Pharma INC. | $22.60 | 2023 | Qutenza |
| Uswm, LLC | $21.54 | 2024 | Lucemyra |
| International Rehabilitative Sciences, INC | $21.00 | 2023 | Rs 4i Plus Sequential Stimulator |
| Vertex Pharmaceuticals Incorporated | $20.38 | 2025 | |
| Vertos Medical, INC. | $18.86 | 2024 | Mild Device Kit |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Almatica Pharma LLC | $18.49 | 2023 | Gralise |
| Boston Scientific Corporation | $17.97 | 2023 | Wavewriter Alpha Prime 16 |
| Lilly USA, LLC | $16.76 | 2023 | Emgality, Reyvow |
| Si-Bone, INC. | $14.00 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Goike listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.